News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
oryzon pic
ORYZON announces FDA approval of IND for FRIDA, a Phase Ib trial with iadademstat in R/R AML FLT3mut+ patients
Healthcare
In combination with gilteritinib Primary objectives: to assess safety, tolerability and RP2D…
Partners - Oryzon Genomics
antonio molina
#NewMember | "We consider it a priority to be part of AseBio. It is a key driver of biotech and a leader in opinion generation and dissemination"
Climate change
Meet the Centre for Plant Biotechnology and Genomics (CBGP, UPM-INIA/CSIC), our new member. We…
AseBio - Center for Plant Biotechnology and Genomics (CBGP, UPM-INIA/CSIC)
Illumina Accelerator Startup Funding
Illumina Accelerator Startup Funding
Healthcare
About Illumina for Startups At Illumina, we’re committed to unlocking the power of the genome, and…
Partners - Illumina
coronavirus
Two years of the pandemic: Nearly 30% of new research into Covid-19 by our members is carving a path to the public
Coronavirus
Over 53 biotech organisations are working on 170 solutions to the pandemic and 27% of them have…
specipig
Specipig closes 2021 with 150 biomedical research projects
Healthcare
Company is positioned as a reference preclinical CRO for the development of new drugs, advanced…
Partners - SpeciPig
National Cancer Institute
#8M | Growing number of women in R&D at biotech companies
Services · Talento
Women make up 58% of all R&D staff, but hold only 24.4% of executive positions in the biotech…
Ysios Capital refuerza su equipo con la incorporación de Thomas Harth como Principal
Ysios Capital strengthens its team with the appointment of Thomas Harth as Principal
This key addition will strengthen the Ysios Capital team, which is currently investing its fund…
Partners - Ysios Capital Partners
Dámaso Molero - CEO 3P Biopharmaceuticals
Dámaso Molero, CEO of 3P Biopharmaceuticals, appointed member of the Technical Committee of the Interdepartmental Commission for Personalized Medicine of Navarra
Personalized medicine
Navarra advances in the Comprehensive Strategy for Personalized Medicine with the constitution of…
Partners - 3PBIOVIAN
Farmaindustria Fenin y Raicex publican un estudio sobre atracción de talento
AseBio, RAICEX, Farmaindustria and Fenin launch a study to better attract international talent
Services · Talento
Over 80% of Spanish scientists abroad surveyed would like to return to Spain, but only 24% really…